Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Radioimmunotherapy of glioblastoma multiforme - Current status and future prospects.
Crit Rev Oncol Hematol. 2021 Jul;163:103395. doi: 10.1016/j.critrevonc.2021.103395. Epub 2021 Jun 10.
Crit Rev Oncol Hematol. 2021.
PMID: 34119657
Review.
Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma: A Review of the Current Status of Literature.
Hull A, Li Y, Bartholomeusz D, Hsieh W, Allen B, Bezak E.
Hull A, et al.
Cancers (Basel). 2020 Feb 19;12(2):481. doi: 10.3390/cancers12020481.
Cancers (Basel). 2020.
PMID: 32092952
Free PMC article.
Review.
Item in Clipboard
Preliminary Development and Testing of C595 Radioimmunoconjugates for Targeting MUC1 Cancer Epitopes in Pancreatic Ductal Adenocarcinoma.
Hull A, Li Y, Bartholomeusz D, Hsieh W, Tieu W, Pukala TL, Staudacher AH, Bezak E.
Hull A, et al.
Cells. 2022 Sep 24;11(19):2983. doi: 10.3390/cells11192983.
Cells. 2022.
PMID: 36230945
Free PMC article.
Item in Clipboard
In vitro characterisation of [177Lu]Lu-DOTA-C595 as a novel radioimmunotherapy for MUC1-CE positive pancreatic cancer.
Hull A, Hsieh W, Tieu W, Bartholomeusz D, Li Y, Bezak E.
Hull A, et al.
EJNMMI Radiopharm Chem. 2023 Aug 14;8(1):18. doi: 10.1186/s41181-023-00204-4.
EJNMMI Radiopharm Chem. 2023.
PMID: 37578571
Free PMC article.
Item in Clipboard
Development of [225Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibration.
Hull A, Hsieh W, Borysenko A, Tieu W, Bartholomeusz D, Bezak E.
Hull A, et al.
EJNMMI Radiopharm Chem. 2023 Sep 7;8(1):22. doi: 10.1186/s41181-023-00209-z.
EJNMMI Radiopharm Chem. 2023.
PMID: 37679594
Free PMC article.
Item in Clipboard
The Expression Profile and Textural Characteristics of C595-Reactive MUC1 in Pancreatic Ductal Adenocarcinoma for Targeted Radionuclide Therapy.
Hull A, Li Y, Bartholomeusz D, Hsieh W, Escarbe S, Ruszkiewicz A, Bezak E.
Hull A, et al.
Cancers (Basel). 2020 Dec 28;13(1):61. doi: 10.3390/cancers13010061.
Cancers (Basel). 2020.
PMID: 33379259
Free PMC article.
Item in Clipboard
Cite
Cite